Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis
Copyright © 2021 Elsevier Inc. All rights reserved..
Diagnostic stewardship interventions can decrease unnecessary antimicrobial therapy and microbiology laboratory resources and costs. This retrospective cross-sectional study evaluated factors associated with inappropriate initial cerebrospinal fluid (CSF) testing in patients with suspected community-acquired meningitis or encephalitis. In 250 patients, 202 (80.8%) and 48 (19.2%) were suspected meningitis and encephalitis, respectively. 207 (82.8%) patients had inappropriate and 43 (17.2%) appropriate testing. Any inappropriate CSF test was greatest in the immunocompromised (IC) group (n = 54, 91.5%), followed by non-IC (n = 109, 80.1%) and HIV (n = 44, 80%). Ordering performed on the general ward was associated with inappropriate CSF test orders (adjOR 2.81, 95% CI [1.08-7.34]). Laboratory fee costs associated with excessive testing was close to $300,000 per year. A stepwise algorithm defining empiric and add on tests according to CSF parameters and patient characteristics could improve CSF test ordering in patients with suspected meningitis or encephalitis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
---|---|
Enthalten in: |
Diagnostic microbiology and infectious disease - 102(2022), 1 vom: 20. Jan., Seite 115571 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Morrison, Austin R [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Infective Agents |
---|
Anmerkungen: |
Date Completed 20.01.2022 Date Revised 20.01.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.diagmicrobio.2021.115571 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM33306030X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM33306030X | ||
003 | DE-627 | ||
005 | 20231225220847.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.diagmicrobio.2021.115571 |2 doi | |
028 | 5 | 2 | |a pubmed24n1110.xml |
035 | |a (DE-627)NLM33306030X | ||
035 | |a (NLM)34768207 | ||
035 | |a (PII)S0732-8893(21)00263-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Morrison, Austin R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of the selection of cerebrospinal fluid testing in suspected meningitis and encephalitis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.01.2022 | ||
500 | |a Date Revised 20.01.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Inc. All rights reserved. | ||
520 | |a Diagnostic stewardship interventions can decrease unnecessary antimicrobial therapy and microbiology laboratory resources and costs. This retrospective cross-sectional study evaluated factors associated with inappropriate initial cerebrospinal fluid (CSF) testing in patients with suspected community-acquired meningitis or encephalitis. In 250 patients, 202 (80.8%) and 48 (19.2%) were suspected meningitis and encephalitis, respectively. 207 (82.8%) patients had inappropriate and 43 (17.2%) appropriate testing. Any inappropriate CSF test was greatest in the immunocompromised (IC) group (n = 54, 91.5%), followed by non-IC (n = 109, 80.1%) and HIV (n = 44, 80%). Ordering performed on the general ward was associated with inappropriate CSF test orders (adjOR 2.81, 95% CI [1.08-7.34]). Laboratory fee costs associated with excessive testing was close to $300,000 per year. A stepwise algorithm defining empiric and add on tests according to CSF parameters and patient characteristics could improve CSF test ordering in patients with suspected meningitis or encephalitis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Antimicrobial stewardship | |
650 | 4 | |a Cerebrospinal fluid (CSF) testing | |
650 | 4 | |a Diagnostic stewardship | |
650 | 4 | |a Encephalitis | |
650 | 4 | |a Meningitis | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
700 | 1 | |a Jones, Mathew C |e verfasserin |4 aut | |
700 | 1 | |a Makowski, Charles T |e verfasserin |4 aut | |
700 | 1 | |a Samuel, Linoj P |e verfasserin |4 aut | |
700 | 1 | |a Ramadan, Ahmad R |e verfasserin |4 aut | |
700 | 1 | |a Alangaden, George J |e verfasserin |4 aut | |
700 | 1 | |a Davis, Susan L |e verfasserin |4 aut | |
700 | 1 | |a Kenney, Rachel M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diagnostic microbiology and infectious disease |d 1986 |g 102(2022), 1 vom: 20. Jan., Seite 115571 |w (DE-627)NLM01262845X |x 1879-0070 |7 nnns |
773 | 1 | 8 | |g volume:102 |g year:2022 |g number:1 |g day:20 |g month:01 |g pages:115571 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.diagmicrobio.2021.115571 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 102 |j 2022 |e 1 |b 20 |c 01 |h 115571 |